Subject: RXMD Announces a Massive March Revenue Result and Year to Year Consistent Growth

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Announces a Massive March Revenue Result and Year to Year Consistent Growth
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.06

Change (%): + 0.002 (3.33)

Volume: 60,303
RXMD Chart

Progressive Care Inc. Announces March Sales and Issues Acquisition Update

MIAMI, April 23, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for March 2019.

In March, the company reported an 18% increase in prescriptions filled when compared to the same month last year, totaling nearly 27,000 prescriptions generating approximately $1.75 million in net revenue exclusive of PBM fees. Prescriptions filled have increased year over year for the last 18 months as a result of concentrated efforts to promote quality services to new entities including Management Services Organizations (MSOs) and large scale physicians’ practices. Industry wide reimbursement contraction and additional fees has continued to put pressure on net revenues. The Company is moving forward on monetizing core competencies such as B2B services in the healthcare industry and personalized medicinal solutions to insulate the operation from further cost cutting efforts by insurance companies and delivering profitability.

“Progressive Care’s March sales and prescription numbers are a result of our dedicated commitment to providing patients with a range of personalized medication therapies,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are confident in our ability to continue to meet our patients’ needs by providing quality healthcare management services. We look forward to continuing to break company records as the year progresses.”

Update on Acquisition
The Company is nearing completion of its acquisition of Family Physicians RX (FPRX) a South Florida pharmacy with locations in Orlando and Davie, FL. The closing is scheduled to take place in the next 6 weeks to align with Medicaid advanced notification rules. After the closing, the Company will consolidate FPRX’s nearly $1.5 million in monthly sales into its financial statements. The resultant combined company is expected to yield benefits beyond financial results including expansion opportunities in the I-4 corridor of Florida, economies of scale, and development of complimentary relationships and suites of services.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks